ArticleOphthalmology and therapy2017

Resource Use and Real-World Outcomes for Ranibizumab Treat and Extend for Neovascular Age-Related Macular Degeneration in the UK: Interim Results from TERRA.

Yit Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.